DUBLIN–(BUSINESS WIRE)–The “Immunotherapy Drugs: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global immunotherapy drugs marketDUBLIN–(BUSINESS WIRE)–The “Immunotherapy Drugs: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global immunotherapy drugs market
Immunotherapy Drugs Global Markets Report 2025: Historical Revenue Data for 2022-2024, Estimate Figures for 2025, and Forecasts for 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Immunotherapy Drugs: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.
Despite challenges, the immunotherapy field is rapidly evolving, with researchers developing more effective approaches such as personalized cancer vaccines and oncolytic viruses. Immunotherapy has demonstrated its potential for multiple diseases, particularly cancer, with ongoing research likely to yield even more effective and personalized therapies.
The current report provides detailed information on immunotherapy drugs. It analyzes the market trends with data from 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030, including regional markets for immunotherapy drugs. This report highlights the current and future market potential and provides a detailed discussion on the competitive environment. The report will also cover regulatory scenarios, drivers, restraints and opportunities. Additionally, it covers market share data for key companies.
The report aims to:
- Analyze types of immunotherapies.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts through 2030.
- Assess market shares, competitiveness and industry structure.
- Identify potential long-term impacts on the immunotherapy drug market.
The report includes:
- 88 data tables and 57 additional tables
- An overview of the global market for immunotherapy drugs
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, and forecasts for 2030, including projections of CAGRs through 2030
- Evaluation of the current market size and revenue growth prospects specific to the immunotherapy drugs, accompanied by a market share analysis by therapy type, application and region
- Description of immunotherapy and combination immunotherapy, and discussion of how it targets cell-mediated adaptive immunity
- Details of checkpoint inhibitors, monoclonal antibodies, interleukins and interferons; and coverage of innovative strategies and new targeted approaches for immunotherapy
- Analysis of the current and future demands in the global immunotherapy drugs, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting the market’s growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Market share analysis of the key companies in the immunotherapy drugs, along with their research priorities, product portfolios, global rankings and the competitive landscape
- Profiles of major companies in industry, including: F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, and Sanofi
Companies Featured
- Abbvie Inc.
- Amgen Inc.
- Astrazeneca
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences Inc.
- Gsk PLC.
- Johnson & Johnson Services Inc.
- Lilly
- Merck & Co.Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 231 |
| Forecast Period | 2025 – 2030 |
| Estimated Market Value (USD) in 2025 | $260.7 Billion |
| Forecasted Market Value (USD) by 2030 | $467.4 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Overview
- Macroeconomic Factor Analysis
- Impact of U.S. Tariffs on the Pharmaceutical Industry
- Healthcare Expenditure
- Impact of GDP on the Pharma Sector
- Porter’s Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Incidence of Chronic Diseases
- Increasing R&D Spending by Market Players
- Rise in Government Funding and Pharmaceutical R&D Spending
- Market Restraints
- High Cost of Immunotherapy Drugs
- Rising Generic Competition
- Lack of Skilled Professionals
- Market Opportunities
- Technological Advances in Immunotherapy
- Potential in Immunotherapy
Chapter 4 Regulatory Landscape
- Overview
- U.S.
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
- Overview
- AI and ML
- Emergent Biomarkers
- Genome Editing and CRISPR
- Pipeline Analysis
- Key Takeaways
- Patent Analysis
- Key Takeaways
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Global Market for Immunotherapy Drugs, by Therapy Type
- Key Takeaways
- Monoclonal Antibodies
- Checkpoint Inhibitors
- Cytokines
- Others
- Global Immunotherapy Drug Market, by Application
- Key Takeaways
- Cancer
- Autoimmune Diseases
- Chronic Inflammatory Respiratory Condition
- Geographic Breakdown
- Global Market for Immunotherapy Drugs by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Company Share Analysis
Chapter 8 Sustainability in Immunotherapy Drugs Market: An ESG Perspective
- Introduction to ESG
- Sustainability in the Immunotherapy Drug Market
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance Impact
- ESG Risk Ratings
- Conclusion
For more information about this report visit https://www.researchandmarkets.com/r/qypknq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Market Opportunity
4 Price(4)
$0.02437
$0.02437$0.02437
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
The Channel Factories We’ve Been Waiting For
The post The Channel Factories We’ve Been Waiting For appeared on BitcoinEthereumNews.com. Visions of future technology are often prescient about the broad strokes while flubbing the details. The tablets in “2001: A Space Odyssey” do indeed look like iPads, but you never see the astronauts paying for subscriptions or wasting hours on Candy Crush. Channel factories are one vision that arose early in the history of the Lightning Network to address some challenges that Lightning has faced from the beginning. Despite having grown to become Bitcoin’s most successful layer-2 scaling solution, with instant and low-fee payments, Lightning’s scale is limited by its reliance on payment channels. Although Lightning shifts most transactions off-chain, each payment channel still requires an on-chain transaction to open and (usually) another to close. As adoption grows, pressure on the blockchain grows with it. The need for a more scalable approach to managing channels is clear. Channel factories were supposed to meet this need, but where are they? In 2025, subnetworks are emerging that revive the impetus of channel factories with some new details that vastly increase their potential. They are natively interoperable with Lightning and achieve greater scale by allowing a group of participants to open a shared multisig UTXO and create multiple bilateral channels, which reduces the number of on-chain transactions and improves capital efficiency. Achieving greater scale by reducing complexity, Ark and Spark perform the same function as traditional channel factories with new designs and additional capabilities based on shared UTXOs. Channel Factories 101 Channel factories have been around since the inception of Lightning. A factory is a multiparty contract where multiple users (not just two, as in a Dryja-Poon channel) cooperatively lock funds in a single multisig UTXO. They can open, close and update channels off-chain without updating the blockchain for each operation. Only when participants leave or the factory dissolves is an on-chain transaction…
Share
BitcoinEthereumNews2025/09/18 00:09
Successful Medical Writing from Protocol to CTD Training Course: Understand International Guidelines and Standards (Mar 23rd – Mar 24th, 2026) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Successful Medical Writing – from Protocol to CTD Training Course (Mar 23rd – Mar 24th, 2026)” training has been added to ResearchAndMarkets
Share
AI Journal2026/01/03 01:15
Italy passes law on AI outlining privacy and child access
The post Italy passes law on AI outlining privacy and child access appeared on BitcoinEthereumNews.com. Italy has formally passed a sweeping new law to regulate artificial intelligence, becoming the first member of the European Union to roll out comprehensive legislation in step with the bloc’s landmark AI Act. The Italian Senate granted final approval after a year of debate, concluding what Prime Minister Giorgia Meloni’s government described as a decisive step in shaping how new technologies are deployed across the country. Italy sets tough penalties for offenders The legislation, ministers argue, lays out the boundaries for human-centric, transparent, and safe use of AI while balancing the need to foster innovation, cybersecurity, and economic growth. The law casts its net widely, and it stretches into healthcare, schools, the justice system, workplaces, sport, and the public sector. AI access for children under 14 has also been tightened, and it now requires parental consent. “This law brings innovation back within the perimeter of the public interest, steering AI toward growth, rights and full protection of citizens.” Alessio Butti, the undersecretary for digital transformation. Lawmakers also opted for a hard line on abuses. A new offence has been added to the criminal code covering the unlawful spread of AI-generated or manipulated content, such as deepfakes. Anyone found guilty faces between one and five years in prison if their actions cause harm. Using AI to commit fraud, identity theft, market manipulation, or money laundering will now be treated as an aggravating circumstance, raising potential sentences by a third. Judges remain the sole authority in legal rulings, though courts are empowered to demand rapid takedowns of illicit material. Government agencies to oversee its implementation Responsibility for enforcing the regime lies with the Agency for Digital Italy and the National Cybersecurity Agency, though existing financial watchdogs such as the Bank of Italy and Consob retain powers in their own spheres. The Department…
Share
BitcoinEthereumNews2025/09/18 06:05